PCR Inhibitors: Sources, Detection, and Removal Strategies

PCR inhibitors are substances that interfere with polymerase chain reaction amplification, reducing assay sensitivity or producing false-negative results. They occur naturally in clinical specimens, environmental samples, food matrices, and soil, and they act through diverse mechanisms including polymerase interference, nucleic acid degradation, and co-purification with target DNA. This article explains where inhibitors originate, how they interfere with amplification, how to detect their presence using internal controls, and which removal strategies have demonstrated effectiveness across different sample types. The content is written for laboratory students, technicians, researchers, and diagnostic professionals who need practical guidance for troubleshooting inhibited reactions and selecting appropriate cleanup methods.

What Are PCR Inhibitors and Why Do They Matter

PCR inhibitors are compounds that reduce the efficiency of DNA polymerase activity, interfere with primer annealing, or degrade nucleic acids during extraction and amplification. They can originate from the sample matrix itself, from reagents used during nucleic acid extraction, or from collection and storage materials. The polymerase chain reaction is increasingly used as the standard method for detection and characterization of microorganisms and genetic markers in a variety of sample types, yet the method is prone to inhibiting substances that may be present in the analyzed sample and may affect assay sensitivity or even lead to false-negative results [6].

Inhibitors represent a diverse group of substances with different properties and mechanisms of action. Some are predominantly found in specific types of samples, which necessitates matrix-specific protocols for preparation of nucleic acids before PCR [6]. A diagnostic laboratory that processes multiple sample types must therefore validate extraction and amplification procedures for each matrix instead of assuming a single protocol works universally.

The practical consequence of inhibition is straightforward: a sample that contains a pathogen or genetic target may test negative because the amplification reaction never proceeds efficiently. This outcome has serious implications in clinical diagnostics, food safety testing, environmental monitoring, and forensic analysis. False-negative results can delay treatment, allow contaminated products to reach consumers, or compromise legal investigations.

Common Sources of PCR Inhibitors by Sample Type

Clinical Specimens

Human and animal clinical samples contain a range of substances that inhibit PCR. Feces are particularly problematic because they contain complex polysaccharides, bile salts, bilirubin, and plant-derived compounds from diet. A study of Helicobacter pylori detection in human feces found that a diet completely free of plant material for two days was sufficient to eliminate PCR inhibitors from stool samples, but inhibitors reappeared within 48 hours after a normal diet was resumed [10]. This finding demonstrates that dietary components are a major source of inhibition in fecal samples and that inhibitor levels can fluctuate based on patient diet.

Blood and serum contain heme, hemoglobin, and immunoglobulins that can interfere with amplification. Urine may contain urea and other metabolic byproducts. Tissue samples often contain lipids and proteins that co-purify with DNA during extraction. The diversity of inhibitory compounds in clinical specimens means that no single extraction method works for all sample types.

Environmental and Water Samples

Surface water, seawater, soil, and sediment contain humic acids, fulvic acids, and metal ions that are potent PCR inhibitors. Humic acid is a particularly well-studied inhibitor because it binds to DNA and interferes with polymerase activity. Electromembrane extraction studies have demonstrated that humic acid at concentrations of 0.2 and 2.5 mg/mL can be cleared by 94% and 85% respectively using this approach, while calcium ions at 275 mM can be cleared by 63% [9]. These high-level inhibitors can hardly be sufficiently removed by conventional DNA extraction approaches and may result in complete failure of PCR [9].

Ballast tank sediments present a complex challenge because they combine high inhibitor loads with the presence of relic DNA from dead organisms. A study addressing viable bacteria detection in ballast tank sediments found that inhibitor removal unmasked the true community abundance, yielding a 16-fold increase in 16S rRNA gene copies and a significant restructuring of the microbial composition [12]. This finding illustrates that inhibition can dramatically underestimate microbial abundance in environmental samples.

Food and Agricultural Matrices

Food samples present unique challenges because they contain matrix-specific inhibitors that vary by commodity. Cilantro samples processed for detection of Cyclospora cayetanensis have shown partial or total inhibition of PCR reactions, leading to decreased sensitivity or false-negative results [11]. Oysters and other shellfish accumulate inhibitors from their filter-feeding behavior, and activated charcoal has been investigated as a means of removing PCR inhibitors from oyster samples [23].

Produce such as green onions, lettuces, radishes, and strawberries can inhibit reverse transcription PCR used for norovirus detection. A study evaluating inhibitor-removal treatment for noroviruses in water and produce found that recovery efficiencies increased clearly in surface and seawater samples with the inhibitor-removal treatment compared to untreated samples, and murine norovirus was well recovered from all four types of produce with the treatment [8].

Forensic and Mineral Samples

Forensic samples, soil, food, and mineral medicines may contain powerful PCR inhibitors that resist removal by standard extraction methods [9]. Forensic samples often contain dyes, denim components, and environmental contaminants that inhibit amplification. Mineral medicines can contain high concentrations of metal ions, particularly calcium, that interfere with PCR. The presence of these inhibitors can cause complete failure of short tandem repeat genotyping, which is the standard method for human identification in forensic casework.

Mechanisms of PCR Inhibition

Polymerase Interference

Many inhibitors directly interfere with DNA polymerase enzyme activity. Humic acids bind to the polymerase enzyme and prevent it from incorporating nucleotides into the growing DNA strand. Metal ions such as calcium can compete with magnesium, which is an essential cofactor for polymerase function. The result is reduced amplification efficiency that may manifest as delayed cycle threshold values or complete absence of amplification.

Nucleic Acid Binding and Degradation

Some inhibitors bind directly to DNA templates, preventing primers from annealing or polymerase from processive extension. Others promote nucleic acid degradation during extraction or storage. A study of Helicobacter pylori DNA stability in feces showed that DNA was degraded after three days of contact with fecal material at 37 degrees Celsius [10]. This finding has practical implications for sample storage and transport, particularly in settings where cold chain maintenance is difficult.

Co-purification During Extraction

Inhibitors often co-purify with nucleic acids during extraction because they share similar chemical properties. Humic acids are negatively charged like DNA and precipitate under similar conditions. Polysaccharides can form viscous solutions that trap DNA and inhibitors together. This co-purification means that extraction methods must be specifically designed to separate inhibitors from nucleic acids instead of simply recovering DNA.

Detecting PCR Inhibition

Internal Amplification Controls

The most reliable method for detecting inhibition is the use of an internal amplification control, which is a known quantity of nucleic acid that is co-amplified with the target sequence in the same reaction. If the internal control fails to amplify or shows delayed cycle threshold values, inhibition is present. The World Health Organization Laboratory Quality Management System Handbook provides guidance on quality control procedures for diagnostic laboratories, including the use of controls to verify test performance [1].

Internal controls should be included in every PCR run to distinguish true negative results from false negatives caused by inhibition. A sample that tests negative for the target but also fails to amplify the internal control should be reported as inhibited instead of negative, and the sample should be re-extracted or diluted before retesting.

Cycle Threshold Value Assessment

In quantitative PCR, cycle threshold values provide a measure of amplification efficiency. Samples with inhibition often show delayed cycle threshold values compared to expected values for the same concentration of target. The internal amplification control cycle threshold values can be compared to a normal range established during assay validation. A study of commercial DNA cleanup kits for Cyclospora detection in cilantro used internal amplification control cycle threshold values to assess whether inhibition was reduced to levels considered normal for noninhibited samples [11].

Serial Dilution Testing

Serial dilution of extracted nucleic acid can reveal inhibition because dilution reduces inhibitor concentration. If amplification improves with dilution, inhibition is present. However, dilution also reduces target concentration, which can lead to false negatives if the target is present at low levels. This approach is therefore most useful as a diagnostic tool instead of a routine processing method.

Matrix-Specific Validation

Because inhibitors vary by sample type, validation should be performed for each matrix processed in the laboratory. The National Center for Advancing Translational Sciences Assay Guidance Manual provides information on assay development and validation, including considerations for sample preparation and interference testing [3]. Validation should include spiking experiments where known quantities of target nucleic acid are added to representative samples to verify that the full workflow can detect the target at the required sensitivity.

Strategies for Removing PCR Inhibitors

Commercial DNA Cleanup Kits

Commercial cleanup kits are the most accessible option for laboratories that encounter inhibition. These kits use various principles including silica membrane binding, size exclusion, and proprietary inhibitor-binding resins. A comparative study of five commercial DNA cleanup kits for Cyclospora detection in cilantro found that all five kits reduced internal amplification control cycle threshold values to those considered normal for noninhibited samples, allowing unambiguous interpretation of results in cilantro samples seeded at both high and low oocyst levels [11].

However, the same study found significant differences in target DNA recovery among kits. Kits 1, 2, and 3 did not show significant differences in detection of Cyclospora cayetanensis, while significantly higher cycle threshold values, indicating lower recovery of target DNA, were observed from kits 4 and 5 in samples seeded with 200 and 10 oocysts [11]. This finding demonstrates that inhibitor removal effectiveness and DNA recovery are separate performance characteristics that must both be evaluated when selecting a cleanup kit.

Agarose Embedded DNA Blocks

A technique using agarose blocks containing embedded DNA as a template for PCR amplification was developed for removal of inhibitors from fecal samples. When applied to inhibiting stool samples spiked with Helicobacter pylori, a positive PCR was obtained, showing that inhibitors present in the original DNA samples were completely removed [10]. The agarose embedded DNA block method provides clean, high quality template DNA for PCR purposes while avoiding long and fastidious conventional extraction methods [10].

This method works by physically separating DNA from inhibitors during the amplification process. The agarose matrix allows small molecules like nucleotides and primers to diffuse while retaining larger molecules including inhibitors and DNA. The approach is particularly useful for samples with high inhibitor loads that resist other cleanup methods.

Electromembrane Extraction

Electromembrane extraction is a newer approach that uses an electric field to migrate charged inhibitors out of the sample while leaving PCR analytes behind. During electromembrane extraction, charged inhibitors in the sample migrate into a liquid membrane in the presence of an electric field and might further leach into the waste solution, while PCR analytes remain in the sample [9]. This technique has demonstrated high clearance values for humic acid and calcium ions, and it significantly reduced interference by humic acid in forensic short tandem repeat analysis [9].

Electromembrane extraction can be combined with liquid-liquid extraction or solid-phase extraction to achieve satisfactory short tandem repeat profiles from humic acid-rich blood samples [9]. The approach also prevented false-negative reports of bacterial detection in mineral medicine and shrimps after removal of calcium ions [9]. This technique is particularly valuable for samples with high-level inhibitors that cannot be removed by conventional methods.

Activated Charcoal Treatment

Activated charcoal has been investigated for removal of PCR inhibitors from oyster samples [23]. Charcoal adsorbs organic compounds including many PCR inhibitors, and it can be incorporated into extraction protocols as a cleanup step. This approach is inexpensive and accessible, making it suitable for laboratories with limited budgets.

Aqueous Two-Phase Systems

Aqueous two-phase systems have been used for sample preparation prior to PCR to remove inhibitors from human fecal samples [24]. These systems separate molecules based on differential partitioning between two immiscible aqueous phases, allowing inhibitors to be separated from nucleic acids. This approach has been available since the 1990s and remains relevant for challenging sample types.

Dilution and Re-Extraction

Simple dilution of extracted nucleic acid can reduce inhibitor concentration to levels that allow amplification. However, dilution also reduces target concentration and may lead to false negatives when targets are present at low levels. Re-extraction using a different method may be more effective than dilution because it can physically separate inhibitors from nucleic acids.

At a Glance: PCR Inhibitor Sources and Removal Options

Practical Workflow for Managing PCR Inhibition

Step 1: Establish Baseline Performance

Before troubleshooting inhibition, establish baseline performance for each assay and sample type. Run amplification reactions with known positive controls to document expected cycle threshold values and amplification curves. The U.S. Food and Drug Administration Bioanalytical Method Validation Guidance provides a framework for validating analytical methods, including assessment of selectivity and interference [4]. Baseline data are essential for distinguishing normal assay variation from inhibition.

Step 2: Include Internal Controls in Every Run

Internal amplification controls should be included in every PCR run, beyond during validation. The internal control provides real-time evidence of inhibition for each individual sample. A sample that fails to amplify the internal control is inhibited regardless of whether the target sequence amplifies. This practice is fundamental to quality management in diagnostic laboratories [1].

Step 3: Document Inhibition Events

Maintain records of inhibition events including sample type, extraction method, internal control cycle threshold values, and any cleanup steps applied. These records help identify patterns such as specific sample types that consistently show inhibition or extraction batches that introduce inhibitors. The World Health Organization Laboratory Quality Management System Handbook emphasizes the importance of documentation for quality improvement [1].

Step 4: Select Cleanup Method Based on Sample Type

Choose cleanup methods based on the specific sample matrix and the inhibitor types likely present. Commercial cleanup kits are appropriate for moderate inhibition, while electromembrane extraction or agarose embedded DNA blocks may be necessary for high inhibitor loads. Evaluate cleanup methods using spiked samples to verify both inhibitor removal and target DNA recovery.

Step 5: Verify Cleanup Effectiveness

After applying a cleanup method, verify effectiveness by confirming that internal control cycle threshold values return to normal ranges and that positive controls still amplify at expected levels. For quantitative assays, verify that target quantification is not affected by the cleanup process. The National Center for Advancing Translational Sciences Assay Guidance Manual provides guidance on assay validation and quality control [3].

Step 6: Escalate Persistent Problems

If inhibition persists after applying standard cleanup methods, escalate the problem according to laboratory protocols. Persistent inhibition may indicate a need for different extraction chemistry, additional purification steps, or consultation with the assay manufacturer. Document all escalation steps and outcomes for future reference.

Records and Measurements for Inhibition Management

Laboratories should maintain detailed records of inhibition-related quality control data. These records support troubleshooting, method validation, and continuous quality improvement. The following measurements are relevant:

Internal amplification control cycle threshold values for every sample processed. These values provide quantitative evidence of inhibition and allow comparison across samples and runs.

Inhibitor clearance values for cleanup methods, expressed as the percentage of inhibitor removed from the sample. Electromembrane extraction studies have reported clearance values of 94% and 85% for humic acid at different concentrations and 63% for calcium ions [9].

Recovery efficiency of target nucleic acid through the complete workflow, from extraction through cleanup to amplification. Recovery efficiency should be measured using spiked samples with known target concentrations.

False-negative rates by sample type, calculated as the proportion of known positive samples that test negative due to inhibition. These rates identify sample types that require enhanced cleanup procedures.

Cycle threshold value distributions for positive controls across runs, which detect shifts in assay performance over time.

Common Failure Patterns in PCR Inhibition Management

Failure to Detect Inhibition

The most common failure is the absence of internal controls in PCR runs. Without internal controls, inhibited samples produce false-negative results that are reported as true negatives. This failure has serious consequences in diagnostic testing because it can lead to missed diagnoses or release of contaminated products. Internal controls should be considered mandatory for all diagnostic PCR testing [1].

Inadequate Cleanup for High Inhibitor Loads

Conventional DNA extraction approaches may not sufficiently remove high levels of inhibitors, resulting in complete failure of PCR [9]. Laboratories that process environmental samples, soil, or mineral medicines may encounter inhibitor levels that exceed the capacity of standard cleanup kits. These samples require specialized approaches such as electromembrane extraction or combined cleanup methods.

Ignoring Matrix-Specific Differences

Inhibitors are predominantly found in specific types of samples, necessitating matrix-specific protocols for preparation of nucleic acids before PCR [6]. A protocol that works for blood may fail for feces or soil. Laboratories must validate extraction and cleanup procedures for each sample type they process instead of assuming universal applicability.

Overlooking DNA Recovery

Cleanup methods that effectively remove inhibitors may also reduce target DNA recovery. The comparative study of commercial cleanup kits found that some kits showed significantly higher cycle threshold values, indicating lower recovery of target DNA, even though all kits reduced inhibition to acceptable levels [11]. Laboratories must evaluate both inhibitor removal and DNA recovery when selecting cleanup methods.

Assuming Inhibition Is Absent in Clean Samples

Even samples that appear clean can contain inhibitors. Surface water and seawater samples showed increased recovery of noroviruses with inhibitor-removal treatment compared to untreated samples, demonstrating that inhibition was present even in water samples [8]. Laboratories should not assume that clear or colorless samples are free of inhibitors.

Limitations of Current Removal Strategies

No Universal Removal Method

No single method removes all PCR inhibitors from all sample types. Inhibitors represent a diverse group of substances with different properties and mechanisms of action [6]. A method that effectively removes humic acids may not remove calcium ions, and a method that works for feces may not work for blood. Laboratories must maintain a toolbox of cleanup methods and select based on sample type and inhibitor profile.

Cleanup Methods Can Introduce New Problems

Cleanup methods can introduce their own inhibitors or reduce target recovery. Commercial kits vary in performance, with some showing significantly lower target DNA recovery than others [11]. Additional processing steps increase the risk of contamination and sample loss. Laboratories must balance the benefits of inhibitor removal against the risks of additional processing.

Inhibitor Removal May Not Restore Degraded DNA

Some inhibitors cause nucleic acid degradation instead of simply interfering with amplification. Helicobacter pylori DNA was degraded after three days of contact with fecal material at 37 degrees Celsius [10]. Cleanup methods cannot restore DNA that has already been degraded. Sample collection, transport, and storage conditions are therefore critical for preserving nucleic acid integrity.

Quantification Challenges

Inhibitor removal can complicate quantitative PCR by affecting the relationship between cycle threshold values and target concentration. The 16-fold increase in 16S rRNA gene copies observed after inhibitor removal in ballast tank sediments demonstrates that inhibition can dramatically affect quantitative results [12]. Laboratories performing quantitative assays must validate that cleanup methods do not introduce quantification bias.

Safety and Quality Context

Biosafety Considerations

Sample processing for PCR involves handling potentially infectious materials. The World Health Organization Laboratory Biosafety Manual provides guidance on safe handling of biological specimens, including appropriate containment practices and personal protective equipment [2]. Laboratories should follow biosafety level requirements appropriate for the sample types they process.

Quality Management

PCR inhibition management is a component of overall laboratory quality management. The World Health Organization Laboratory Quality Management System Handbook describes the components of a quality management system, including quality control, quality assurance, and continuous improvement [1]. Inhibition management should be integrated into these broader quality systems instead of treated as an isolated technical issue.

Method Validation

The U.S. Food and Drug Administration Bioanalytical Method Validation Guidance provides a framework for validating analytical methods, including assessment of selectivity, sensitivity, and interference [4]. Validation should include testing with representative sample matrices to identify inhibition issues before methods are used for diagnostic testing. The National Center for Advancing Translational Sciences Assay Guidance Manual also provides relevant guidance on assay development and validation [3].

Professional Escalation Criteria

Laboratory personnel should escalate inhibition problems to supervisors or quality managers when:

Inhibition persists after applying standard cleanup methods, indicating a need for different extraction chemistry or specialized cleanup approaches.

Internal control failures occur at rates above established thresholds, suggesting systematic issues with reagents, extraction methods, or sample collection procedures.

Quantitative results are inconsistent with clinical or environmental expectations, suggesting possible inhibition-related bias.

New sample types are introduced that have not been validated for inhibition.

Cleanup methods produce inconsistent results across runs, indicating a need for method reevaluation.

Frequently Asked Questions

What is the most common cause of PCR inhibition in clinical samples?

Fecal samples contain complex polysaccharides, bile salts, and plant-derived compounds that are potent PCR inhibitors. A study of Helicobacter pylori detection in feces found that a diet completely free of plant material for two days eliminated PCR inhibitors from stool samples, but inhibitors reappeared within 48 hours after a normal diet was resumed [10]. Blood samples are commonly inhibited by heme and hemoglobin, while tissue samples may contain lipids that co-purify with DNA.

How do I know if my PCR reaction is inhibited?

The most reliable indicator is failure of the internal amplification control. If the internal control does not amplify or shows delayed cycle threshold values, inhibition is present. Other indicators include delayed cycle threshold values for positive controls, poor amplification curves, and improved amplification after sample dilution. The World Health Organization Laboratory Quality Management System Handbook emphasizes the importance of quality control procedures for verifying test performance [1].

Can dilution solve PCR inhibition problems?

Dilution can reduce inhibitor concentration to levels that allow amplification, but it also reduces target concentration and may lead to false negatives when targets are present at low levels. Dilution is most useful as a diagnostic tool to confirm that inhibition is present instead of as a routine processing method. For samples with high inhibitor loads, physical removal methods such as electromembrane extraction or commercial cleanup kits are more appropriate [9].

Which commercial DNA cleanup kits work best for removing inhibitors?

Kit performance varies by sample type and inhibitor profile. A comparative study of five commercial DNA cleanup kits for Cyclospora detection in cilantro found that all five kits reduced internal amplification control cycle threshold values to normal levels, but some kits showed significantly lower recovery of target DNA than others [11]. Laboratories should evaluate cleanup kits using their own sample types and target assays instead of relying on manufacturer claims alone.

What are humic acids and why do they inhibit PCR?

Humic acids are complex organic compounds found in soil, water, and sediment. They inhibit PCR by binding to DNA polymerase and interfering with enzyme activity. Electromembrane extraction studies have demonstrated clearance values of 94% and 85% for humic acid at different concentrations [9]. Humic acids are particularly problematic in environmental samples and can cause complete failure of PCR if not removed.

How does electromembrane extraction remove PCR inhibitors?

Electromembrane extraction uses an electric field to migrate charged inhibitors out of the sample into a liquid membrane and potentially into a waste solution, while PCR analytes remain in the sample [9]. This technique has demonstrated high clearance values for both anionic inhibitors like humic acid and cationic inhibitors like calcium ions, and it can be combined with other extraction methods for challenging samples [9].

Why do food samples like cilantro and oysters inhibit PCR?

Food samples contain matrix-specific compounds that inhibit PCR. Cilantro samples have shown partial or total inhibition of quantitative PCR reactions, leading to decreased sensitivity or false-negative results [11]. Oysters accumulate inhibitors from their filter-feeding behavior, and activated charcoal has been investigated for removing PCR inhibitors from oyster samples [23]. Produce such as green onions, lettuces, radishes, and strawberries can also inhibit reverse transcription PCR used for norovirus detection [8].

What should I do if my PCR remains inhibited after cleanup?

If inhibition persists after applying standard cleanup methods, escalate the problem according to laboratory protocols. Consider using a different cleanup method, such as electromembrane extraction for high inhibitor loads [9] or agarose embedded DNA blocks for fecal samples [10]. Evaluate whether the extraction chemistry is appropriate for the sample type, and consult the assay manufacturer if problems persist. Document all steps taken for future reference.

Related Diagnostic Guides

• PCR Inhibition: Causes, Detection, and Remedies
• Digital Droplet PCR (ddPCR) for Absolute Quantification of Swine Enteric Coronaviruses in Fecal and Oral Fluid Samples: Analytical Sensitivity and Clinical Utility
• Multiplex Real-Time RT-PCR for Simultaneous Detection of Porcine Circovirus Type 3, Porcine Parvovirus, and Torque Teno Sus Virus in Clinical Swine Samples
• Development and Clinical Validation of a Multiplex Real-Time RT-PCR Panel for Simultaneous Detection and Subtyping of Avian Influenza Virus (H5, H7, H9) and Newcastle Disease Virus in Poultry Respiratory Samples
• Development of an Aptamer-Based Electrochemical Biosensor for Rapid Detection of Canine Parvovirus in Clinical Samples

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PCR inhibitors - occurrence, properties and removal.. Journal of applied microbiology, 2012.
• USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer.. Theranostics, 2020.
• Improved real-time quantitative reverse transcription PCR detection of norovirus following removal of inhibitors.. Heliyon, 2021.
• Removal of Polymerase Chain Reaction Inhibitors by Electromembrane Extraction.. Analytical chemistry, 2021.
• Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors.. Journal of microbiological methods, 2001.
• Assessment of Commercial DNA Cleanup Kits for Elimination of Real-Time PCR Inhibitors in the Detection of Cyclospora cayetanensis in Cilantro.. Journal of food protection, 2020.
• Optimizing viable bacteria detection in ballast tank sediments: Addressing PCR inhibitors and relic DNA.. Ecotoxicology and environmental safety, 2026.
• O-GlcNAc of STING mediates antiviral innate immunity.. Cell communication and signaling : CCS, 2024.
• Protocol for enhancing CRISPR-Cas9 genome editing using histone deacetylase inhibition and engineered virus-like particle delivery.. 2026.
• Protocol for combining BMP, MEK, WNT inhibition and iNGN2 to enable rapid neuronal differentiation and regional patterning from hiPSCs.. 2026.
• Protocol for rapid allelic discrimination qPCR genotyping of the Winnie mouse model.. 2026.
• Comparison of two DNA extraction methods for the detection of zoonotic protozoan pathogens in oysters and seawater.. 2026.
• Systematic pegRNA design with PRIDICT2.0 and ePRIDICT for efficient prime editing.. 2026.
• Role of histone acetylation in the regulation of CD36 and ANGPTL1 in esophageal squamous cell carcinoma.. 2025.
• Correlation Between Infectivity and qRT-PCR Values for Murine Norovirus Recovered from Frozen Berries.. 2025.
• Improving SARS-CoV-2 RNA Detection in Wastewater: Comparison of Concentration Methods and the Effect of PCR Inhibitor Removal on Detection Sensitivity. Food and Environmnetal Virology, 2026.
• A Rapid, Cost-Effective RNA Recovery of Cowpea Mild Mottle Virus (CPMMV) Directly from PCR Tubes Adsorption for Routine-Scale Detection in Soybean. Viruses, 2025.
• The use of activated charcoal for the removal of PCR inhibitors from oyster samples.. Journal of Microbiological Methods, 2007.
• Removal of PCR inhibitors from human faecal samples through the use of an aqueous two-phase system for sample preparation prior to PCR. 1997.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.